Exactech, Inc. (NASDAQ:EXAC)

CAPS Rating: 5 out of 5

The Company designs, manufactures, markets and distributes orthopaedic implant devices including knee, hip, shoulder and ankle joint replacement systems, bone allograft materials, surgical instrumentation, and bone cement and accessories.

Results 1 - 20 of 29 : 1 2 Next »

Recs

0
Member Avatar Staka (98.03) Submitted: 1/12/2014 5:50:53 AM : Outperform Start Price: $23.64 EXAC Score: -6.32

Positive:
- Much potential growth in this area
- Compared to their industry they are still cheap
- Reasonable debt

Negative:
- Technology risks, patients might file complaints

Category: PVm

Recs

0
Member Avatar TerryHoodSr (49.09) Submitted: 7/29/2013 10:59:22 PM : Outperform Start Price: $18.99 EXAC Score: +5.31

growth

Recs

1
Member Avatar WilliamCrook2003 (71.47) Submitted: 3/26/2012 12:08:15 PM : Outperform Start Price: $16.56 EXAC Score: +4.31

A company which would be a great buy for MAKO Surgical if they decide to buy out a company which produces implants for them. There appears to be a growing need for their implants due to great companies like MAKO having great sucess in the industry in which this company operates in.

Recs

0
Member Avatar whomonkyoulus (28.68) Submitted: 6/11/2010 4:35:00 PM : Outperform Start Price: $17.80 EXAC Score: -42.30

Profitable, cash positive, small-cap in a monster market. Someone will buy them, but I hope they don't.

Recs

0
Member Avatar foolstracker (< 20) Submitted: 4/11/2010 5:35:55 PM : Outperform Start Price: $19.67 EXAC Score: -41.38

stock of the day

Recs

0
Member Avatar W0kthisway21 (< 20) Submitted: 3/16/2010 5:59:12 PM : Outperform Start Price: $19.00 EXAC Score: -41.27

It has great potential because it is one of the Company that is doing well in a recession. Surely, once the economy improves, it will outperform not only the S&P but other indexes.

Recs

0
Member Avatar lola99999 (< 20) Submitted: 11/25/2009 4:38:05 PM : Outperform Start Price: $16.07 EXAC Score: -32.00

EXAC

Recs

0
Member Avatar kevinottofro (99.05) Submitted: 8/2/2009 8:10:39 AM : Outperform Start Price: $14.25 EXAC Score: -29.74

Low relative PE, good star ranking, PEG & 09 PE still below normal - bottom fishing 7/27 picks (late getting them in this week).

Recs

0
Member Avatar surfacescrub (< 20) Submitted: 3/1/2009 10:06:06 PM : Outperform Start Price: $13.77 EXAC Score: -98.25

Baby Boomers . . I work in PT and there is no shortage of these sorts of surgeries. There is also no end to the innovation in which joints can be replaced and how those components are made.

Recs

0
Member Avatar Rbbarn7ExicteCom (< 20) Submitted: 2/19/2009 12:37:00 PM : Outperform Start Price: $15.46 EXAC Score: -95.25

POST BY RBBARN7EXCITECOM
MY BEST PICK

Recs

0
Member Avatar SuperCharge (89.14) Submitted: 2/14/2009 5:48:36 PM : Outperform Start Price: $14.49 EXAC Score: -74.92

Recent quarterly earnings have fallen much less than the price of the stock. Aside from potential regulation, I'm bullish on orthopaedics for the mid-term but I'd be a lot more comfortable with this pick if there were insiders buying.

Recs

0
Member Avatar stockguy07 (< 20) Submitted: 7/30/2008 12:33:01 PM : Outperform Start Price: $30.16 EXAC Score: -76.82

TM

Recs

0
Member Avatar tixareforkids (46.61) Submitted: 7/16/2008 5:00:22 PM : Outperform Start Price: $31.11 EXAC Score: -81.33

Planning for my future in more than one way...

Recs

0
Member Avatar emarw (62.29) Submitted: 7/16/2008 3:02:38 PM : Outperform Start Price: $30.94 EXAC Score: -82.69

Turning grey to green. Gotta love that.

Recs

1
Member Avatar AHavoc (< 20) Submitted: 7/2/2008 8:16:27 PM : Outperform Start Price: $27.93 EXAC Score: -70.79

Institutional investors are driving up volume; quarterlies, eps, good; new technology, known by surgeons as "leader"; demand for product will grow with aging population; earmarks of a healthy stock opportunity.

Recs

0
Member Avatar shekoe (< 20) Submitted: 6/20/2008 8:41:20 AM : Outperform Start Price: $26.19 EXAC Score: -58.76

Another play on the graying of America. It makes artificial knees, etc. Also involved with innovative substances that stimulate cartilage growth. Might be "cure" for arthritis. PE is 33, sales growing rapidly.

Recs

0
Member Avatar bbubbba (28.33) Submitted: 5/9/2008 10:43:18 PM : Outperform Start Price: $24.30 EXAC Score: -46.26

Solid growth!

Recs

0
Member Avatar vjdantone (48.30) Submitted: 4/25/2008 9:33:42 AM : Outperform Start Price: $25.99 EXAC Score: -52.23

I'm down on my knees for this stock.....as the boomers age and need more body parts.....

Recs

1
Member Avatar lb1951 (82.33) Submitted: 3/5/2008 8:53:22 PM : Underperform Start Price: $27.41 EXAC Score: +64.02

Has had a great 12 months --time to consolidate

Recs

0
Member Avatar munypro (< 20) Submitted: 1/20/2008 3:22:25 PM : Outperform Start Price: $22.00 EXAC Score: -50.47

With the babyboomers becoming retirees and they being one of the fasters growing portions of the population, it only stands to reason that this companies products will be in high demand.

Results 1 - 20 of 29 : 1 2 Next »

Featured Broker Partners


Advertisement